Lupin announced the exclusive launch of its Ranolazine Extended-Release (ER) Tablets, 500mg and 1000mg. Lupin's Ranolazine ER Tablets, 500mg and 1000mg are a generic version of Gilead Sciences, Inc.'s Ranexa ER
Tablets, 500mg and 1000 mg. Ranolazine is indicated for the treatment of chronic angi na. Ranolazine ER Tablets, 500mg and 1000mg had an annual sales of approximately USD 945 million in the US (IQVIA MAT December 2018).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
